Attached files

file filename
EX-32.1 - EXHIBIT 32.1 CERT OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 - IMMUNOMEDICS INCimmu201910k1231ex3211.htm
EX-31.2 - EXHIBIT 31.2 CERT OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302(A) - IMMUNOMEDICS INCimmu201910k1231ex3121.htm
EX-31.1 - EXHIBIT 31.1 CERT OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) - IMMUNOMEDICS INCimmu201910k1231ex3111.htm
EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING - KPMG LLP - IMMUNOMEDICS INCimmu201910k1231ex2311.htm
EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES OF THE COMPANY - IMMUNOMEDICS INCimmu201910k1231ex2111.htm
EX-10.9 - EXHIBIT 10.9 LEASE AGREEMENT - IMMUNOMEDICS INCimmu201910k1231ex109.htm
EX-4.1 - EXHIBIT 4.1 DESCRIPTION OF SECURITIES OF THE REGISTRANT - IMMUNOMEDICS INCimmu201910kex41.htm
10-K - 10-K - 12/31/2019 - IMMUNOMEDICS INCimmu201910-k.htm


Exhibit 32.2
 
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Immunomedics. Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 27, 2020
 
/s/Usama Malik
 
Usama Malik
 
Chief Financial Officer
 
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.